Laccetti, A. et al. Oral EPI-7386 in Patients with Metastatic Castration-Resistant Prostate Cancer: Results From the First-in-Human Dose Escalation Phase 1a Study. Prostate Cancer Foundation (PCF) 2022 Scientific Retreat.

Read More > PCF 2022 Poster Presentation